Communicable Diseases Intelligence Volume 29 Issue No 1, March 2005
Composition of Australian Influenza Vaccine for the 2005 season
This page details the recommended composition of the influenza vaccine to be used in the Southern Hemisphere for the 2005 influenza season.
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
This issue - Vol 29 No 1, March 2005
Communicable Diseases Intelligence
The Australian Influenza Vaccine Committee on Influenza Vaccines met on 5 October 2004 and agreed to adopt the September World Health Organization (WHO) recommendations.
The Committee decided that the influenza vaccine components for the 2005 Southern Hemisphere Season should contain the following.
Strain |
Recommended strain | Dose |
|---|---|---|
| A h1N1 strain: | an A/New Caledonia/20/99 (h1N1)-like strain
A/New Caledonia/20/99 (IVR-116) is also recommended as a suitable vaccine strain. |
15 µg HA per dose |
| A h3N2 strain: | an A/Wellington/1/2004 (h3N2)-like strain
A/Wellington/1/2004 (IVR-139) is also recommended as suitable vaccine strain. |
15 µg HA per dose |
| B Strain: | a B/Shanghai/361/2002-like strain
B/Jiangsu/10/2003 is also recommended as a suitable vaccine strain. |
15 µg HA per dose |
This article was published in Communicable Diseases Intelligence Vol 29 No 1 March 2005.
